M. Kochanny

发表

Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1*

Marc Adler, M. Adler, M. Whitlow, 2005, Journal of Biological Chemistry.

Predictions of CCR1 Chemokine Receptor Structure and BX 471 Antagonist Binding Followed by Experimental Validation*

Ravinder Abrol, Nagarajan Vaidehi, Wely B. Floriano, 2006, Journal of Biological Chemistry.

Substituted thiophene-anthranilamides as potent inhibitors of human factor Xa.

M. Adler, M. Whitlow, M. Morrissey, 2007, Bioorganic & medicinal chemistry.

Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517.

M. Adler, M. Whitlow, R. Feldman, 2007, Bioorganic & medicinal chemistry letters.

Fluorine-substituted corticosteroids: synthesis and evaluation as potential receptor-based imaging agents for positron emission tomography of the brain.

M. Welch, M. Pomper, J. Katzenellenbogen, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors.

M. Welch, J. Katzenellenbogen, H. VanBrocklin, 1993, Journal of medicinal chemistry.

Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.

H. Ye, J. Parkinson, G. Phillips, 2008, Bioorganic & medicinal chemistry letters.

Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.

H. Ye, D. Davey, J. Parkinson, 2008, Bioorganic & Medicinal Chemistry Letters.

Regiospecific aryl nitration of meso-substituted tetraarylporphyrins: a simple route to bifunctional porphyrins

M. Kochanny, W. J. Kruper, T. A. Chamberlin, 1989 .

Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.

D. Davey, K. Eagen, M. Morrissey, 2003, Bioorganic & medicinal chemistry letters.

Discovery and characterization of a potent and selective non-amidine inhibitor of human factor Xa.

J. Morser, D. Light, M. Kochanny, 2003, Biochemical pharmacology.

Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.

Bin Ye, David Light, Marc Adler, 2007, Journal of medicinal chemistry.

Crystal structures of two potent nonamidine inhibitors bound to factor Xa.

Bin Ye, Marc Adler, M. Adler, 2002, Biochemistry.

Design, synthesis, and biological activity of novel factor Xa inhibitors: 4-aryloxy substituents of 2,6-diphenoxypyridines.

K. Eagen, M. Morrissey, G. Phillips, 2002, Bioorganic & medicinal chemistry.

Inverse Electron Demand Diels-Alder Reactions of Heterocyclic Azadienes: [4 + 2] Cycloaddition Reaction of Amidines with 1,3,5-Triazines

D. Boger, M. Kochanny, 1994 .

Design, synthesis, and evaluation of potential GAR and AICAR transformylase inhibitors.

D. Boger, S. Benkovic, L. T. Gooljarsingh, 1998, Bioorganic & medicinal chemistry.

Synthesis and NMR spectrum of [13C18]‐meso‐hexestrol, a fully carbon‐13 substituted ligand for NMR studies of the estrogen receptor

J. Katzenellenbogen, T. Härd, M. Kochanny, 1993 .

Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.

J. Haeggström, M. Adler, M. Whitlow, 2008, Bioorganic & medicinal chemistry.

Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity.

M. Adler, M. Whitlow, R. Feldman, 2007, Bioorganic & medicinal chemistry letters.

Imaging agents for brain corticosteroid receptors: Synthesis and tissue distribution of 21-[18F]fluoro-deacylcortivazol

M. Welch, M. Pomper, H. VanBrocklin, 1991 .